Previous Article | Next Article ![]()
Journal of Clinical Microbiology, August 1999, p. 2493-2497, Vol. 37, No. 8
Unitat de Microbiologia, Facultat de Medicina
i Ciències de la Salut, Universitat Rovira i Virgili, 43201-Reus,
Spain,1 and Laboratorio de Micologia,
Hospital Universitario Clementino Fraga Filho, Universidade Federal
do Rio de Janeiro, Rio de Janeiro, Brazil2
Received 21 December 1998/Returned for modification 18 February
1999/Accepted 30 April 1999
Two fungal isolates recovered from the blood of two
immunosuppressed patients are described as Phialemonium
curvatum. One patient died, while the other, who was infected
with Exophiala jeanselmei at the same time, survived after
successful treatment with itraconazole. Analysis of internal
transcribed spacer sequences demonstrated that the isolates belonged to
the same strain and that the source of infection was probably a
catheter. The taxonomic position of P. curvatum is
discussed, and Phialemonium dimorphosporum is considered a
synonym. The in vitro inhibitory activities of six antifungal agents
(amphotericin B, itraconazole, ketaconazole, miconazole, flucytosine,
and fluconazole) were determined against seven isolates of
Phialemonium. Except for flucytosine, all of them were
remarkably effective. Phialemonium should be added to the
list of potential causes of nosocomial fungemia in cancer patients.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Phialemonium Fungemia: Two
Documented Nosocomial Cases
*
Corresponding author. Mailing address: Unitat de
Microbiologia, Departament de Ciències Mèdiques
Bàsiques, Facultat de Medicina i Ciències de la Salut,
Universitat Rovira i Virgili, Carrer Sant Llorenç 21, 43201-Reus,
Tarragona, Spain. Phone: 34 977759359. Fax: 34 977759322. E-mail:
umb{at}fmcs.urv.es.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|